# Scenario run report

**LIVE run (real LLM; models: gemini-3.5-flash, gemini-3.1-flash-lite)**

Totals: 42 pass, 5 fail, 12 need human review, 1 hypotheses not confirmed.

Statuses: `pass`/`fail` are objective checks; `review` needs a human; `differs` means the agent did not confirm one of our written gap hypotheses.

## Event 1: Baseline records arrive from Hospitals A and C
*2026-11-02T09:00*

Fatima (72) has kidney disease, type 2 diabetes, hypertension and atrial fibrillation, and a recorded penicillin allergy. Cardiology (A) uploads warfarin and ramipril; endocrinology (C) uploads metformin. No lab results are on file yet.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding MISSING:DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| safety | no 'interaction' findings | none | none | **pass** |
| safety | no 'contraindication' findings | none | none | **pass** |
| safety | no 'lab-rule' findings | none | none | **pass** |
| consent | C_reads_A_meds | {'allowed': True, 'reason_code': 'GRANTED'} | {'allowed': True, 'reason_code': 'GRANTED', 'escalate': False} | **pass** |
| policy | expectation for human review | Metformin cannot be assessed without eGFR: flag as uncertain, do not guess. | see agent output (conflicts, caveats, gaps) | **review** |
| audit | audit trail has 'grant_created' | present | present | **pass** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

## Event 2: Hospital B (Dubai) prescribes spironolactone
*2026-11-03T10:00*

Nephrology at Hospital B, in a different emirate, adds spironolactone. The patient already takes ramipril and has kidney disease. Neither hospital knows about the other's prescription unless data is shared.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-INT-002 present | present | present | **pass** |
| safety | finding MISSING:DEMO-LAB-002:aldactone present | present | present | **pass** |
| safety | finding MISSING:DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | severity of DEMO-INT-002 | high | high | **pass** |
| consent | A_reads_B_meds | {'allowed': True, 'reason_code': 'GRANTED'} | {'allowed': True, 'reason_code': 'GRANTED', 'escalate': False} | **pass** |
| consent | B_reads_A_meds | {'allowed': True, 'reason_code': 'GRANTED'} | {'allowed': True, 'reason_code': 'GRANTED', 'escalate': False} | **pass** |
| policy | cites uae-health-ict-law-2019 ('confidentiality of health data') | cited | not cited | **fail** |
| policy | cites dha-health-info-sharing-2024 ('Consent must be obtained') | cited | not cited | **fail** |
| policy | cites doh-hie-policy-2020 ('Universal') | cited | ['doh-hie-policy-2020#0021'] | **pass** |
| policy | expectation for human review | Two emirate regimes apply (Abu Dhabi DoH and Dubai DHA); sharing here rests on the patient's grants. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CONSENT-REGIME-DIVERGENCE: hypothesis | Abu Dhabi's HIE policy (DoH 2020, s4.2) makes participation mandatory and authorizes sharing even when consent | likely match: 'Uniformity of Consent Requirements' (ambiguity) | **review** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

**Policy agent** (3 searches, completed=True)
- *requirement:* In Abu Dhabi, healthcare facilities are required to obtain patient consent for sharing patient data via the ADHIE, though the Department of Health (DOH) mandates and authorizes sharing even if consent is unavailable for legacy data or as otherwise required by DOH. [doh-hie-policy-2020#0021, doh-hie-policy-2020#0022]
- *requirement:* In Dubai, healthcare facilities are not required to obtain patient consent for uploading health information to NABIDH, but they must include a clause regarding sharing PHI with NABIDH in their general patient consent forms. [dha-consent-access-standard-2025#0017]
- *requirement:* Under UAE Federal Law No. (2) of 2019, patient data must be kept confidential and not used for non-health purposes without written consent, except in specific cases defined by legislation. [dha-health-info-sharing-2024#0016]
- *requirement:* In Dubai, accessing PHI without patient consent through Health Information Systems (HIS) is permitted in special cases as defined by UAE Federal Law No. (2) of 2019, DHA Health Data Protection and Confidentiality Policy, and the DHA Policy for Health Information Sharing. [dha-consent-access-standard-2025#0014]
- *gap (ambiguity):* **Uniformity of Consent Requirements**: While both Dubai and Abu Dhabi operate under the umbrella of UAE Federal Law No. (2) of 2019, their specific HIE policies (NABIDH in Dubai and ADHIE in Abu Dhabi) differ in their explicit requirements for patient consent for data sharing. Abu Dhabi policy emphasizes obtaining consent while providing a mandate for sharing if consent is unavailable, whereas Dubai policy states consent is not required for uploading data to NABIDH but requires inclusion of a sharing clause in general consent forms. [doh-hie-policy-2020#0021, doh-hie-policy-2020#0022, dha-consent-access-standard-2025#0017]
- ⚠ Sent back once: only 2 search(es) before answering

## Event 3: Overdue lab results arrive three days late
*2026-11-06T16:00*

eGFR and potassium were taken on 3 Nov but only reach the system on 6 Nov. Until now the system had to treat both as unknown.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-LAB-002:aldactone present | present | present | **pass** |
| safety | finding DEMO-INT-002 present | present | present | **pass** |
| safety | finding MISSING:DEMO-LAB-001:glucophage absent | absent | absent | **pass** |
| safety | finding MISSING:DEMO-LAB-002:aldactone absent | absent | absent | **pass** |
| safety | severity of DEMO-LAB-001:glucophage | high | high | **pass** |
| safety | severity of DEMO-LAB-002:aldactone | high | high | **pass** |
| policy | expectation for human review | Earlier 'missing lab' uncertainty is resolved by the late result; the log must show both states. | see agent output (conflicts, caveats, gaps) | **review** |

## Event 4: Patient withdraws consent for Hospital B's data and opts out of NABIDH
*2026-11-07T11:00*

Fatima revokes every grant covering Hospital B's records and opts out of the Dubai exchange. From now on the platform must stop using Hospital B's data. Earlier sharing is already on record.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| safety | finding DEMO-LAB-002:aldactone absent | absent | absent | **pass** |
| safety | limitation notice mentions HospitalB | present | present | **pass** |
| consent | A_reads_B_meds_direct | {'allowed': False, 'reason_code': 'REVOKED'} | {'allowed': False, 'reason_code': 'REVOKED', 'escalate': False} | **pass** |
| consent | A_reads_B_meds_exchange | {'allowed': False, 'reason_code': 'OPTED_OUT_OF_EXCHANGE'} | {'allowed': False, 'reason_code': 'OPTED_OUT_OF_EXCHANGE', 'escalate': False} | **pass** |
| policy | cites dha-consent-access-standard-2025 ('right to withdraw') | cited | ['dha-consent-access-standard-2025#0018'] | **pass** |
| policy | cites dha-consent-access-standard-2025 ('retain such information') | cited | ['dha-consent-access-standard-2025#0018'] | **pass** |
| policy | expectation for human review | The assessment is now incomplete by the patient's choice and must say so. | see agent output (conflicts, caveats, gaps) | **review** |
| policy | expectation for human review | Information already shared may stay in recipients' records. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CONSENT-REGIME-DIVERGENCE: hypothesis | Abu Dhabi's HIE policy (DoH 2020, s4.2) makes participation mandatory and authorizes sharing even when consent | not raised by the agent (hypothesis not confirmed) | **differs** |
| audit | audit trail has 'grant_revoked' | present | present | **pass** |
| audit | audit trail has 'exchange_opt_out' | present | present | **pass** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

**Policy agent** (2 searches, completed=True)
- *requirement:* The withdrawal of consent does not affect any sharing of health information that was carried out under consent prior to the withdrawal. [dha-consent-access-standard-2025#0018]
- *requirement:* Any entity that accessed or received health information via the Health Information System (HIS) prior to the revocation of consent and incorporated that information into its records may retain that information. [dha-consent-access-standard-2025#0018]
- *requirement:* If a patient opts out of the Health Information System (HIS), personal health information should continue to be received by the HIS from the entity, but patient identifiers must be anonymized in accordance with UAE Federal Law No. (45) of 2021 and the Policy for Health Data Protection and Confidentiality. [dha-consent-access-standard-2025#0018]
- *requirement:* Following an opt-out from the Health Information System (HIS), personal health information should not be retrieved using 'Break the Glass' (BTG) access. [dha-consent-access-standard-2025#0018]
- *comparison:* Under EU GDPR, the withdrawal of consent does not affect the lawfulness of processing based on consent before its withdrawal. [eu-gdpr-2016-679#0092, eu-gdpr-2016-679#0102]
- *gap (no_provision_found):* **Specific Opt-out/Withdrawal Procedures for Malaffi (Abu Dhabi)**: While the DHA Standards provide clear procedures for NABIDH (Dubai) regarding consent withdrawal and opt-out effects, the provided knowledge base does not contain specific provisions detailing the effect of patient consent withdrawal or opt-out procedures for the Malaffi (Abu Dhabi) exchange. []
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): Standards for Health Information Consent and Access Control, Version 1 (2025), p.19 [dha-consent-access-standard-2025#0015]; Policy for Health Information Sharing (2024), p.15 [dha-health-info-sharing-2024#0015]
- ⚠ Sent back once: only 1 search(es) before answering

## Event 5: Emergency: clinician at Hospital A requests Hospital B's medication list
*2026-11-08T02:30*

Fatima arrives unconscious at Hospital A with bleeding. The doctor needs her full medication list, including Hospital B's, and requests break-the-glass access. She has opted out of NABIDH.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| consent | ED_btg_B_meds | {'allowed': False, 'reason_code': 'EMERGENCY_BLOCKED_BY_OPT_OUT', 'escalate': True} | {'allowed': False, 'reason_code': 'EMERGENCY_BLOCKED_BY_OPT_OUT', 'escalate': True} | **pass** |
| policy | cites uae-health-ict-law-2019 ('health and safety of the patient') | cited | not cited | **fail** |
| policy | cites dha-consent-access-standard-2025 ('should not be retrieved using BTG') | cited | ['dha-consent-access-standard-2025#0018'] | **pass** |
| policy | cites dha-consent-access-standard-2025 ('emergency condition') | cited | not cited | **fail** |
| policy | cites dha-consent-access-standard-2025 ('Emirate of Dubai') | cited | not cited | **fail** |
| policy | expectation for human review | Federal Art. 16(3) health-and-safety exception conflicts with DHA 9.7 opt-out rule. | see agent output (conflicts, caveats, gaps) | **review** |
| policy | expectation for human review | The system must escalate to a human and must not silently override either rule. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CROSS-EMIRATE-EMERGENCY-ACCESS: hypothesis | DHA's break-the-glass rules cover Dubai entities and bar BTG retrieval for opted-out patients (s9.7), while fe | likely match: 'Cross-emirate emergency access procedures' (scope_unclear) | **review** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

**Escalated to a human:** Emergency access was not granted because the patient opted out of NABIDH. A human decision is required.

**Policy agent** (3 searches, completed=True)
- *requirement:* Under Dubai Health Authority (DHA) standards (DHA/HISHD/ST-09), Personal Health Information (PHI) of a patient who has opted out of the Health Information System (HIS) must not be retrieved using Break-the-Glass (BTG) access. [dha-consent-access-standard-2025#0018]
- *requirement:* Under UAE Federal Law (Cabinet Resolution No. 32 of 2020), in an emergency where patient consent cannot be obtained, healthcare providers may examine a patient's file for healthcare purposes, provided they supply reasons for the examination. [uae-health-ict-exec-reg-2020#0007]
- *conflict:* There is a potential conflict between the Dubai-specific prohibition on BTG access for opted-out patients and the broader UAE federal provision allowing emergency access to patient files when consent cannot be obtained. The text does not clarify which rule takes precedence in a cross-emirate exchange scenario. [dha-consent-access-standard-2025#0018, uae-health-ict-exec-reg-2020#0007]
- *gap (scope_unclear):* **Cross-emirate emergency access procedures**: The provided texts do not specify the governing rules for emergency access when a clinician in one emirate (Abu Dhabi) requests data from a facility in another emirate (Dubai) where the patient has opted out of the local exchange (NABIDH). It is unclear whether the rules of the requesting facility's jurisdiction, the providing facility's jurisdiction, or a federal standard applies. [dha-consent-access-standard-2025#0018, uae-health-ict-exec-reg-2020#0007]
- ⚠ Sent back once: only 1 search(es) before answering
- ⚠ Removed citation 'dha-hie-policy-2020#0053' from requirements: not retrieved in this run
- ⚠ Removed citation 'dha-hie-policy-2020#0054' from requirements: not retrieved in this run
- ⚠ Dropped uncited requirement: 'Under the Abu Dhabi Department of Health (DoH) Policy on the Abu Dhabi Health In'
- ⚠ Removed citation 'dha-hie-policy-2020#0053' from gap: not retrieved in this run

## Event 6: Who owns the follow-up?
*2026-11-08T09:00*

With eGFR 24 and potassium 5.4 on record, Hospital C asks which institution is responsible for coordinating the response across three prescribers in two emirates.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| safety | limitation notice mentions HospitalB | present | present | **pass** |
| policy | expectation for human review | If no provision assigning cross-institution responsibility is found in the ingested KB, say so and list what w | see agent output (conflicts, caveats, gaps) | **review** |
| policy | expectation for human review | Absence in the KB is not proof that no rule exists elsewhere. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CROSS-INSTITUTION-RESPONSIBILITY: hypothesis | Hypothesis: no ingested provision assigns responsibility for coordinating follow-up on medication findings tha | likely match: 'Responsibility for cross-emirate clinical coordination' (no_provision_found) | **review** |

**Policy agent** (8 searches, completed=True)
- *comparison:* EU regulations (EHDS) establish that importers of EHR systems must investigate complaints and follow up on information received regarding incidents involving their systems, keeping relevant parties informed. [eu-ehds-2025-327#0128]
- *comparison:* EU regulations (EHDS) note that when natural persons restrict access to their health data, they should assume responsibility for the fact that the healthcare provider cannot take that data into account when providing health services, though access should remain possible in emergency situations to protect vital interests. [eu-ehds-2025-327#0010]
- *gap (no_provision_found):* **Responsibility for cross-emirate clinical coordination**: There is no provision in the provided texts that explicitly assigns responsibility for coordinating clinical follow-up or medication safety responses between healthcare facilities located in different emirates (e.g., Abu Dhabi and Dubai). While policies emphasize sectoral coordination and the importance of health information exchange for continuity of care, they do not define the specific clinical governance or accountability mechanisms for multi-prescriber, cross-emirate scenarios. []
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): DoH Policy on the Abu Dhabi Health Information Exchange (April 2020), p.10 [doh-hie-policy-2020#0011]
- *gap (no_provision_found):* **Impact of patient-withheld data on clinical responsibility**: The provided texts do not specify how a patient's choice to withhold data from a health information exchange (such as NABIDH) affects the clinical responsibility or duty of care of a provider who is unable to access that data for safety assessments. []
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): Standards for Health Information Consent and Access Control, Version 1 (2025), p.10 [dha-consent-access-standard-2025#0007]; Policy for Health Information Sharing (2024), p.15 [dha-health-info-sharing-2024#0015]; Standards for Health Information Consent and Access Control, Version 1 (2025), p.9 [dha-consent-access-standard-2025#0006]
- ⚠ Sent back once: only 3 search(es) before answering
